Baker Bros. Advisors’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-753,064
| Closed | -$1.13M | – | 112 |
|
|
2023
Q1 | $1.13M | Hold |
753,064
| – | – | 0.01% | 98 |
|
|
2022
Q4 | $752K | Hold |
753,064
| – | – | ﹤0.01% | 102 |
|
|
2022
Q3 | $1.36M | Hold |
753,064
| – | – | 0.01% | 102 |
|
|
2022
Q2 | $2.18M | Hold |
753,064
| – | – | 0.01% | 96 |
|
|
2022
Q1 | $2.08M | Hold |
753,064
| – | – | 0.01% | 100 |
|
|
2021
Q4 | $3.51M | Buy |
753,064
+576,603
| +327% | +$2.69M | 0.02% | 99 |
|
|
2021
Q3 | $1.5M | Hold |
176,461
| – | – | 0.01% | 113 |
|
|
2021
Q2 | $2.9M | Hold |
176,461
| – | – | 0.01% | 106 |
|
|
2021
Q1 | $3.9M | Buy |
176,461
+65,573
| +59% | +$1.45M | 0.02% | 102 |
|
|
2020
Q4 | $3.43M | Sell |
110,888
-11,644
| -10% | -$360K | 0.01% | 100 |
|
|
2020
Q3 | $2.49M | Buy |
+122,532
| New | +$2.49M | 0.01% | 98 |
|